Serina Therapeutics, Inc. (SER)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $1.64
- As of
Kresmion compiles this page from SER's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Serina Therapeutics, Inc. (SER): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-10-09.
See the full SER dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for SER on one page. Preview it with sample data, then open it live with a free account.
Preview the SER dossierActive events for SER
- mediumEarnings below estimates
Q2-2026: Missed consensus by 17.1%, EPS $-0.55 vs $-0.4697 estimate
- mediumEarnings below estimates
Q2-2025: Missed consensus by 53.7% - EPS $-0.66 vs $-0.4293 estimate
- mediumEarnings above estimates
Q4-2025: Beat consensus by 33.3% - EPS $-0.31 vs $-0.4646 estimate
- mediumEarnings below estimates
Q1-2026: Missed consensus by 30.5% - EPS $-0.58 vs $-0.4444 estimate
FREE, NO ACCOUNT
Every event on SER, as it fires
New filings, 13F moves and cross asset events on SER land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, SER
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Related tickers
Follow SER on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to SER for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.